Related Experiment Video
Updated: Jan 26, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Effect of miR-29b on rats with gestational diabetes mellitus by targeting PI3K/Akt signal
1Department of Obstetrics and Gynecology, Juancheng People's Hospital, Heze, China. zjoo81@163.com.
Objective:
To investigate the role of micro-ribonucleic acid-29b (miR-29b) in rats with gestational diabetes mellitus (GDM) through the phosphatidylinositol 3-kinase (PI3K)/serine/threonine kinase (Akt) signal and its mechanism by establishing rat models of GDM.
Materials And Methods:
Rat models of GDM were constructed, and then the expression levels of miR-29b, total PI3K, phosphorylated PI3K (p-PI3K), total Akt and phosphorylated Akt (p-Akt) in the model group and control group were measured via Reverse Transcription-Polymerase Chain Reaction (RT-PCR) and Western blotting assays, and the association between miR-29b expression and total PI3K expression was analyzed. In addition, miR-29b mimics and inhibitors were used to further explore the regulatory pathway, and the influences of miR-29b mimics and inhibitors on PI3K and Akt phosphorylation in GDM rats, characteristic indicators of oxidative stress such as superoxide dismutase (SOD), catalase (CAT) and malondialdehyde (MDA) in liver tissues of GDM rats, and fasting blood glucose in GDM rats were studied.
Results:
Compared with those in the control group, miR-29b expression was lowered in rat models of GDM, while PI3K/Akt signal expression was increased. In rats with GDM, miR-29b expression was prominently negatively correlated with total PI3K expression (r=-0.777, p=0.007, p<0.01). MiR-29b mimics could reduce PI3K and Akt phosphorylation, increase SOD and CAT expression levels and decrease MDA content (p<0.05). Moreover, miR-29b mimics significantly lowered the blood glucose level in rats with GDM (p<0.05).
Conclusions:
MiR-29b mimics can alleviate oxidative stress and reduce blood glucose by inhibiting the PI3K/Akt signal transduction.
Insights
Micro-ribonucleic acid-29b (miR-29b) plays a role in gestational diabetes mellitus (GDM) by regulating the PI3K/Akt pathway. Restoring miR-29b levels in GDM rats reduces oxidative stress and blood glucose.
Area of Science:
- Endocrinology
- Molecular Biology
- Biochemistry
Background:
- Gestational diabetes mellitus (GDM) is a significant pregnancy complication.
- The phosphatidylinositol 3-kinase (PI3K)/serine/threonine kinase (Akt) signaling pathway is implicated in metabolic regulation.
- Micro-ribonucleic acids (miRNAs) are emerging as key regulators in various physiological and pathological processes.
Purpose of the Study:
- To investigate the role of micro-ribonucleic acid-29b (miR-29b) in a rat model of gestational diabetes mellitus (GDM).
- To elucidate the mechanism involving the PI3K/Akt signaling pathway in GDM pathogenesis.
- To assess the therapeutic potential of modulating miR-29b in GDM.
Main Methods:
- Establishment of rat models for GDM.
- Quantification of miR-29b, PI3K, and Akt expression using RT-PCR and Western blotting.
- In vivo manipulation of miR-29b levels using mimics and inhibitors.
- Assessment of oxidative stress markers (SOD, CAT, MDA) and fasting blood glucose levels.
Main Results:
- GDM rats exhibited decreased miR-29b expression and increased PI3K/Akt signaling.
- A significant negative correlation was observed between miR-29b and PI3K expression.
- Administration of miR-29b mimics reduced PI3K/Akt phosphorylation, alleviated oxidative stress, and lowered blood glucose levels in GDM rats.
Conclusions:
- MiR-29b plays a crucial role in the pathogenesis of GDM.
- Inhibition of the PI3K/Akt signaling pathway by miR-29b contributes to its glucose-lowering and anti-oxidative effects.
- Modulating miR-29b represents a potential therapeutic strategy for GDM.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
PI3K/mTOR/AKT Signaling Pathway
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
What is Cell Signaling?
Endocrine Signaling

